Visit COVID-19 resources

[Skip to Content]

Clinical Guidance

Updated Ophthalmic Service Guidance for paediatric ophthalmology (2021)

Aug 19

We’ve updated our Ophthalmic Service Guidance for paediatric ophthalmology! Our 2021 guidance represents the expert consensus, based on available evidence and national guidance, of the Paediatric Sub-committee of The Royal College of Ophthalmologists (RCOphth). Read the Ophthalmic Service for Children Guidance (2021) It highlights best practice and fundamental standards for children’s ophthalmic services. It should

  • 19 August 2021

RCOphth responds to new framework for restarting National Institute of Health Research activities

May 27

The National Insitute of Health Research NIHR has set out a framework to guide the restarting of NIHR research activities which have been paused due to COVID-19. This framework has been developed in cooperation with Devolved Administrations who will produce aligned, but specific guidance for their area. Commenting on the new framework, RCOphth Academic Committee

  • 27 May 2020

NOD Audit will continue to manage services during COVID-19

Apr 01

During these unprecedented times, The Royal College of Ophthalmologists will continue to deliver and manage its services to members where feasible. This includes the NOD Audit, which will continue to be managed by the NOD team and in liaison with trusts and surgeons. The collection of data, analysis and reporting of outcomes for individual surgeons and

  • 1 April 2020

Ophthalmic Safety Alert- Do not use apraclonidine in infants below six months of age

Feb 21

The College has recently received a report from NHS Improvement of a severe adverse reaction in a six month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.  Two drops of apraclonidine 1% were administered to each eye, 30 minutes apart.  Ninety minutes later the child had an acute

  • 21 February 2019

How to protect patients and NHS staff against influenza infection

Sep 13

Flu immunisation remains the most effective method to help protect against influenza infection. Along with other interventions, influenza immunisation is an important tool in preventing and controlling respiratory infections in healthcare settings. Public Health England estimates that an average 8,000 people die from flu in England each year. Some years that figure reaches 14,000. That’s

  • 13 September 2018